<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages>en</availableLanguages>
  <rcn>266548</rcn>
  <id>101162681</id>
  <acronym>AUTO-TARGET</acronym>
  <teaser>Chronic kidney disease (CKD) affects around 10% of the population worldwide and is associated with significant overall and cardiovascular mortality. CKD is a heterogeneous group of disorders characterized by alterations in kidney structure and function and is progressive in...</teaser>
  <objective>Chronic kidney disease (CKD) affects around 10% of the population worldwide and is associated with significant overall and cardiovascular mortality. CKD is a heterogeneous group of disorders characterized by alterations in kidney structure and function and is progressive in nature. Autoimmune diseases are a common cause of CKD and responsible for its most aggressive and progressive forms, mainly in younger patients. Autoantibodies play major pathogenic roles in most of these disorders and multiple disease-specific target antigens have been identified  circumstances that have shifted treatment strategies from largely unspecific immunosuppression towards B and plasma cell-targeted therapies. However, such treatments still involve broad immunosuppression with potentially severe adverse effects. Hence, there is a huge gap between the increasing insights into the immune mechanisms and pathogenic role of autoantibodies against cellular antigens on the one side and the currently available treatments with limited specificity on the other side. The vision of AUTO-TARGET is the development and experimental implementation of pathogenesis-based and antigen-specific treatments for autoimmune diseases of the kidney. The objectives are (1) to identify and characterize novel molecular targets on autoantibody-secreting cells, (2) to target autoreactive B and plasma cells using nanobody-based compounds, and (3) to engineer chimeric autoantibody receptor NK and T cells for the treatment of different autoimmune diseases of the kidney. AUTO-TARGET thereby revolves around a highly translational approach, combining target identification and characterization in patients with autoimmune kidney diseases with unique in vitro and in vivo systems to model disease and validate therapeutics. These translational studies pave the way for more specific, less toxic treatments and thus may implicate a huge step forward for the large and growing population of patients with kidney disease.</objective>
  <title>Antigen-specific treatments to target autoimmune kidney diseases</title>
  <totalCost>1499662.5</totalCost>
  <ecMaxContribution>1499662.5</ecMaxContribution>
  <startDate>2025-04-01</startDate>
  <endDate>2030-03-31</endDate>
  <ecSignatureDate>2024-10-03</ecSignatureDate>
  <duration>60</duration>
  <status>SIGNED</status>
  <keywords>Autoantibodies, monoclonal antibodies, nanobodies, bispecific antibody recruiters, antibody-secreting cells, autoimmune disease, membranous nephropathy, minimal change disease, systemic lupus erythematosis, rapid progressive glomerulonephritis</keywords>
  <identifiers>
    <grantDoi>10.3030/101162681</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2024-12-31 09:30:22</sourceUpdateDate>
  <contentCreationDate>2024-10-09 16:49:07</contentCreationDate>
  <contentUpdateDate>2024-10-09 16:49:05</contentUpdateDate>
  <lastUpdateDate>2025-09-19 14:49:05</lastUpdateDate>
  <relations>
    <associations>
      <call source="corda" type="relatedMasterCall">
        <rcn>56393</rcn>
        <title>ERC-2024-STG</title>
        <identifier>ERC-2024-STG</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>56393</rcn>
        <title>ERC-2024-STG</title>
        <identifier>ERC-2024-STG</identifier>
      </call>
      <organization netEcContribution="1499662.5" totalCost="1499662.5" source="corda" order="1" ecContribution="1499662.5" terminated="false" sme="false" type="coordinator">
        <availableLanguages>en</availableLanguages>
        <rcn>1915515</rcn>
        <id>999857474</id>
        <vatNumber>DE218618948</vatNumber>
        <legalName>UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF</legalName>
        <shortName>UKE</shortName>
        <address>
          <street>Martinistrasse  52</street>
          <city>Hamburg</city>
          <postalCode>20251</postalCode>
          <country>DE</country>
          <postBox>N/A</postBox>
          <url>http://www.uke.uni-hamburg.de</url>
          <geolocation>53.5921787,9.9756013</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/HES</code>
              <title>Higher or Secondary Education Establishments</title>
              <displayCode>/Higher or Secondary Education Establishments</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Hamburg</name>
              <rcn>221798400</rcn>
              <nutsCode>DE600</nutsCode>
              <parents>
                <region>
                  <name>Hamburg</name>
                  <rcn>221798440</rcn>
                  <nutsCode>DE60</nutsCode>
                  <parents>
                    <region>
                      <name>Hamburg</name>
                      <rcn>221801000</rcn>
                      <nutsCode>DE6</nutsCode>
                      <parents>
                        <region>
                          <name>Germany</name>
                          <rcn>221940264</rcn>
                          <nutsCode>DE</nutsCode>
                          <euCode>DE</euCode>
                          <isoCode>DE</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>Germany</name>
              <rcn>221940264</rcn>
              <nutsCode>DE</nutsCode>
              <euCode>DE</euCode>
              <isoCode>DE</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme type="relatedTopic" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>708445</rcn>
        <id>HORIZON_ERC-2024-STG</id>
        <code>ERC-2024-STG</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>ERC STARTING GRANTS</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode>/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme type="relatedLegalBasis" source="corda" uniqueProgrammePart="true">
        <availableLanguages>en</availableLanguages>
        <rcn>705727</rcn>
        <id>HORIZON.1.1</id>
        <code>HORIZON.1.1</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.1.1</pga>
        <title>European Research Council (ERC)</title>
        <parent>
          <programme>
            <rcn>705726</rcn>
            <code>HORIZON.1</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode>/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1319865</rcn>
        <id>101162681_196614_PUBLIHORIZON</id>
        <title>Recent advances in pathogenetic concepts and disease modeling of IgA nephropathy</title>
        <details>
          <authors>Leonie Dreher, Lars Nilges, Thorsten Wiech, Markus M Rinschen, Nicola M Tomas</authors>
          <journalNumber>18</journalNumber>
          <journalTitle>Clinical Kidney Journal</journalTitle>
          <publishedPages></publishedPages>
          <publishedYear>2025</publishedYear>
          <publisher>Oxford University Press (OUP)</publisher>
        </details>
        <identifiers>
          <issn>2048-8505</issn>
          <doi>10.1093/CKJ/SFAF152</doi>
        </identifiers>
        <sourceUpdateDate>2025-07-04 19:26:43</sourceUpdateDate>
        <contentUpdateDate>2025-07-07 15:36:33</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/publication</code>
              <title>Project publication</title>
              <description>Result: Project publications</description>
              <displayCode>/Project publication</displayCode>
            </category>
            <category classification="projectPublication" type="isPublishedAs">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/PEER_REVIEWED_ARTICLE</code>
              <title>Peer reviewed articles</title>
              <displayCode>/Peer reviewed articles</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1319895</rcn>
        <id>101162681_196616_PUBLIHORIZON</id>
        <title>Passive transfer of patient-derived anti-nephrin autoantibodies causes a podocytopathy with minimal change lesions</title>
        <details>
          <authors>Felicitas E. Hengel, Silke Dehde, Oliver Kretz, Jonas Engesser, Tom Zimmermann, Tobias B. Huber, Nicola M. Tomas</authors>
          <journalNumber>135</journalNumber>
          <journalTitle>Journal of Clinical Investigation</journalTitle>
          <publishedPages></publishedPages>
          <publishedYear>2025</publishedYear>
          <publisher>American Society for Clinical Investigation</publisher>
        </details>
        <identifiers>
          <issn>1558-8238</issn>
          <doi>10.1172/JCI186769</doi>
        </identifiers>
        <sourceUpdateDate>2025-07-04 19:26:43</sourceUpdateDate>
        <contentUpdateDate>2025-07-07 15:38:00</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/publication</code>
              <title>Project publication</title>
              <description>Result: Project publications</description>
              <displayCode>/Project publication</displayCode>
            </category>
            <category classification="projectPublication" type="isPublishedAs">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/PEER_REVIEWED_ARTICLE</code>
              <title>Peer reviewed articles</title>
              <displayCode>/Peer reviewed articles</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1319886</rcn>
        <id>101162681_196615_PUBLIHORIZON</id>
        <title>Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategy</title>
        <details>
          <authors>Felicitas E. Hengel, Silke Dehde, Alev Yilmaz, Aysun K. Bayazit, Fatih Ozaltin, Dusan Paripovic, Francesco Emma, Pierre Ronco, Marina Vivarelli, Julien Hogan, Franz Schaefer, Nicola M. Tomas, Tobias B. Huber</authors>
          <journalNumber>107</journalNumber>
          <journalTitle>Kidney International</journalTitle>
          <publishedPages></publishedPages>
          <publishedYear>2025</publishedYear>
          <publisher>Elsevier BV</publisher>
        </details>
        <identifiers>
          <issn>0085-2538</issn>
          <doi>10.1016/J.KINT.2025.01.019</doi>
        </identifiers>
        <sourceUpdateDate>2025-07-04 19:26:43</sourceUpdateDate>
        <contentUpdateDate>2025-07-07 15:36:44</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/publication</code>
              <title>Project publication</title>
              <description>Result: Project publications</description>
              <displayCode>/Project publication</displayCode>
            </category>
            <category classification="projectPublication" type="isPublishedAs">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/PEER_REVIEWED_ARTICLE</code>
              <title>Peer reviewed articles</title>
              <displayCode>/Peer reviewed articles</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode>/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/29/101/553/1353</code>
        <title>mortality</title>
        <displayCode>/social sciences/sociology/demography/mortality</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/39/231/723</code>
        <title>kidney diseases</title>
        <displayCode>/medical and health sciences/clinical medicine/nephrology/kidney diseases</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode>/Digital agenda</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode>/Clean air</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode>/Artificial intelligence</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode>/Climate action</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode>/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages>en</availableLanguages>
        <code>/HORIZON-ERC</code>
        <title>HORIZON ERC Grants</title>
        <description>HORIZON ERC Grants</description>
        <displayCode>/HORIZON ERC Grants</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode>/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>